DK0477971T3 - Humant CNP gen og precursorprotein - Google Patents

Humant CNP gen og precursorprotein

Info

Publication number
DK0477971T3
DK0477971T3 DK91116557T DK91116557T DK0477971T3 DK 0477971 T3 DK0477971 T3 DK 0477971T3 DK 91116557 T DK91116557 T DK 91116557T DK 91116557 T DK91116557 T DK 91116557T DK 0477971 T3 DK0477971 T3 DK 0477971T3
Authority
DK
Denmark
Prior art keywords
precursor protein
human cnp
human
cnp gene
gene
Prior art date
Application number
DK91116557T
Other languages
Danish (da)
English (en)
Inventor
Hisayuki Matsuo
Kenji Kangawa
Shoji Tanaka
Kayoko Fuchimura
Yasunori Tawaragi
Naoto Minamino
Original Assignee
Hisayuki Matsuo
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisayuki Matsuo, Suntory Ltd filed Critical Hisayuki Matsuo
Application granted granted Critical
Publication of DK0477971T3 publication Critical patent/DK0477971T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DK91116557T 1990-09-27 1991-09-27 Humant CNP gen og precursorprotein DK0477971T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP02259698A JP3026354B2 (ja) 1990-09-27 1990-09-27 ヒトｃｎｐ遺伝子及び前駆体蛋白

Publications (1)

Publication Number Publication Date
DK0477971T3 true DK0477971T3 (da) 1998-09-21

Family

ID=17337688

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91116557T DK0477971T3 (da) 1990-09-27 1991-09-27 Humant CNP gen og precursorprotein

Country Status (8)

Country Link
US (1) US6034231A (el)
EP (2) EP0769554B1 (el)
JP (1) JP3026354B2 (el)
AT (2) ATE388165T1 (el)
DE (2) DE69133593T2 (el)
DK (1) DK0477971T3 (el)
ES (2) ES2113865T3 (el)
GR (1) GR3026554T3 (el)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL142118A0 (en) * 2001-03-20 2002-03-10 Prochon Biotech Ltd Method and composition for treatment of skeletal dysplasias
BRPI0203172B8 (pt) 2001-09-28 2021-05-25 Nakao Kazuwa composição farmacêutica para acondroplasia
EP1569683B1 (en) 2002-11-26 2010-03-03 Biocon Limited Modified natriuretic compounds, conjugates, and uses thereof
EP3620530A1 (en) 2004-03-31 2020-03-11 Kazuwa Nakao Composition for increasing body height
ES2465141T3 (es) 2004-03-31 2014-06-05 Kazuwa Nakao Remedio o medicamento preventivo para la artritis
HUE039448T2 (hu) 2004-04-21 2018-12-28 Alexion Pharma Inc Csontba szállító konjugátumok és alkalmazási módszerük a fehérjék csontba juttatására
WO2006076471A2 (en) * 2005-01-12 2006-07-20 Nobex Corporation Bnp conjugates and methods of use
US20070184466A1 (en) * 2005-11-18 2007-08-09 The Brigham And Women's Hospital, Inc. Detection, generation and uses of atherosclerosis-protective endothelium
AR069409A1 (es) * 2007-11-21 2010-01-20 Biomarin Pharm Inc Variantes de peptidos natriureticos de tipo c
PT2277890E (pt) * 2008-05-23 2016-03-31 Daiichi Sankyo Co Ltd Péptido capaz de prolongar o semi-período de vida do péptido de interesse no plasma
HUE032582T2 (en) 2009-05-20 2017-09-28 Biomarin Pharm Inc Variants of C-type natriuretic peptide
US9266939B2 (en) 2010-12-27 2016-02-23 Alexion Pharmaceuticals, Inc. Compositions comprising natriuretic peptides and methods of use thereof
WO2013058833A1 (en) 2011-10-19 2013-04-25 Enobia Canada Limited Partnership Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
US10052366B2 (en) 2012-05-21 2018-08-21 Alexion Pharmaceuticsl, Inc. Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
WO2016007873A1 (en) 2014-07-11 2016-01-14 The Regents Of The University Of Michigan Compositions and methods for treating craniosynostosis
JP6787894B2 (ja) 2014-12-05 2020-11-18 アレクシオン ファーマシューティカルズ， インコーポレイテッド 組換えアルカリホスファターゼを用いた発作の処置
AU2016211447B2 (en) 2015-01-28 2021-09-23 Alexion Pharmaceuticals, Inc. Methods of treating a subject with an alkaline phosphatase deficiency
US9907834B2 (en) 2015-07-30 2018-03-06 Biomarin Pharmaceutical Inc. Use of C-type natriuretic peptide variants to treat skeletal dysplasia
KR102644116B1 (ko) 2015-08-17 2024-03-05 알렉시온 파마슈티칼스, 인코포레이티드 알칼린 포스파타제의 제조
JP6868617B2 (ja) 2015-09-28 2021-05-12 アレクシオン ファーマシューティカルズ， インコーポレイテッド 低ホスファターゼ血症の組織非特異的アルカリホスファターゼ（ｔｎｓａｌｐ）酵素補充療法に有効な投薬計画の特定
JP2018533571A (ja) 2015-10-30 2018-11-15 アレクシオン ファーマシューティカルズ， インコーポレイテッド 患者の頭蓋縫合早期癒合症を治療するための方法
WO2017155569A1 (en) 2016-03-08 2017-09-14 Alexion Pharmaceuticals, Inc. Methods for treating hypophosphatasia in children
US10898549B2 (en) 2016-04-01 2021-01-26 Alexion Pharmaceuticals, Inc. Methods for treating hypophosphatasia in adolescents and adults
WO2017173413A1 (en) 2016-04-01 2017-10-05 Alexion Pharmaceuticals, Inc. Treating muscle weakness with alkaline phosphatases
WO2017214130A1 (en) 2016-06-06 2017-12-14 Alexion Pharmaceuticals, Inc. Metal impact on manufacturing of alkaline phosphatases
WO2018035420A1 (en) 2016-08-18 2018-02-22 Alexion Pharmaceuticals, Inc. Methods for treating tracheobronchomalacia
CN110719786A (zh) 2017-03-31 2020-01-21 阿雷克森制药公司 用于治疗成人和青少年的低磷酸酯酶症(hpp)的方法
JP2021519590A (ja) 2018-03-30 2021-08-12 アレクシオン ファーマシューティカルズ， インコーポレイテッド 糖タンパク質の製造
KR20220063220A (ko) 2019-09-16 2022-05-17 바이오마린 파머수티컬 인크. Cnp 변이체 및 이의 접합체
TW202313663A (zh) 2021-07-09 2023-04-01 美商拜奧馬林製藥公司 Ｃ型利鈉肽變異體治療兒童骨骼發育不良
TW202334188A (zh) 2021-12-07 2023-09-01 美商拜奧馬林製藥公司 Ｃｎｐ療法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1339210C (en) * 1988-05-31 1997-08-05 John Lewicki Recombinant techniques for production of novel natriuretic and vasodilator peptides

Also Published As

Publication number Publication date
JPH04139199A (ja) 1992-05-13
ES2302333T3 (es) 2008-07-01
DE69133593T2 (de) 2009-04-02
ES2113865T3 (es) 1998-05-16
DE69128754T2 (de) 1998-06-04
EP0477971A3 (en) 1992-09-09
EP0477971B1 (en) 1998-01-21
EP0477971A2 (en) 1992-04-01
GR3026554T3 (en) 1998-07-31
ATE162532T1 (de) 1998-02-15
ATE388165T1 (de) 2008-03-15
JP3026354B2 (ja) 2000-03-27
DE69128754D1 (de) 1998-02-26
US6034231A (en) 2000-03-07
DE69133593D1 (de) 2008-04-17
EP0769554B1 (en) 2008-03-05
EP0769554A2 (en) 1997-04-23
EP0769554A3 (en) 1997-05-28

Similar Documents

Publication Publication Date Title
DK0477971T3 (da) Humant CNP gen og precursorprotein
HK1027577A1 (en) Selection of proteins using rna-protein fusions
ES2153037T3 (es) Lacasas purificadas de scytalidium y acidos nucleicos que las codifican.
PT88425A (pt) Dna sequences recombinant dna molecules and processes for producing soluble t4 proteins
DE3884529D1 (de) Leader-anteile zur produktion von rekombinanten proteinen.
DK1490386T3 (da) Nyt polypeptid og nukleinsyrer kodende for dette
MX9606013A (es) Lacasas purificadas de myceliophthora y acidos nucleicos que codifican para las mismas.
ATE182901T1 (de) Für androgen-rezeptor-protein kodierende dna
ATE262038T1 (de) Br96 mutantantikörper die mit menschlichen karzinomen reagieren
ES548617A0 (es) Procedimiento para disociar peptidos y proteinas en el enla-ce metionilo
FI90667C (fi) Menetelmä valmistaa uutta ihmisen tyypin I interferoniproteiinia
DE3886517D1 (de) Menschlicher Prourokinase ähnliches Polypeptid.
EP0723016A3 (en) Leukocyte activation factor
DE59109235D1 (de) Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung
DK130290D0 (da) Lymfokiner, dna-sekvenser, som koder for disse lymfokiner og farmaceutiske midler indeholdende disse lymfokiner
DE69127743D1 (de) Für ein Protein, das sich mit dem Enhancer des Alpha-Fetoprotein verbindet, kodierende DNS
ATE75255T1 (de) Peptid und dafuer kodierendes gen.
IE882662L (en) Dna sequences, recombinant dna molecules for producing¹soluble t4 proteins
ZA886593B (en) Dna sequences,recombinant dna molecules and processes for producing soluble t4 proteins
DE3888078D1 (de) Veränderungsverfahren für Peptide und Proteine.
ATE95238T1 (de) Leader-anteile zur produktion von rekombinanten proteinen.
ITRM920517A1 (it) Procedimento di produzione della proteina sv-iv ricombinante e proteina sv-iv ricombinante.
ATE98990T1 (de) Menschlicher prourokinase aehnliches polypeptid.